Natco Pharma Limited has issued a notice regarding a scheduled meeting of its Board of Directors. The meeting is set to be held on Friday, August 14, 2026.
The primary items of business for the board meeting are:
- Consideration of the Unaudited Financial Results for the quarter ended June 30, 2026.
- Consideration of an interim dividend, if any, for the financial year ending March 31, 2027 (2026-27).
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has announced a trading window closure. The window for dealing in the company's securities by employees, connected persons, and their immediate relatives will be closed from August 7, 2026, to August 16, 2026 (both days inclusive). The trading window will reopen on August 17, 2026.
The notice was signed by Venkat Ramesh Chekuri, Company Secretary & Compliance Officer, and was addressed to the Corporate Relationship Department Managers of BSE Limited and the National Stock Exchange of India Ltd.